Table 4—

Effects of clinical characteristics on antioxidant activities in red blood cell lysate in nonsmall cell lung cancer patients

CharacteristicsnCatalase mU·(gHb)-1p-valueSOD U·(gHb)-1p-valueGPx mU·(gHb)-1p-value
Age yrs
 ≥57987.7 (4.4–16.4)19.0 (8.4–32.6)172.5 (104.8–268.4)
 <57917.4 (4.7–14.9)0.8512.0 (9.2–20.4)0.10186.6 (136.8–330.5)0.14
Sex
 M1267.8 (4.5–22.6)14.8 (9.0–26.8)167.2 (109.0–276.4)
 F637.3 (3.9–13.4)0.3212.7 (8.7–30.2)0.59178.2 (138.4–330.2)0.21
Smoking status
 ES1057.6 (4.5–16.2)16.5 (8.8–31.6)166.7 (103.6–275.1)
 NS848.0 (4.2–14.2)0.6612.6 (9.2–23.5)0.16189.9 (142.7–335.0)0.06
Tumour cell types
 AD1057.3 (4.3–13.4)12.7 (8.7–32.7)175.2 (130.0–320.7)
 Non-AD848.2 (4.5–17.6)0.2515.4 (9.3–24.7)0.59179.6 (116.0–268.5)0.50
Overall TNM stage
 IIIB617.7 (4.7–14.5)17.0 (9.4–44.0)180.2 (129.9–280.7)
 IV1096.9 (4.2–15.1)0.4612.2 (8.2–25.0)0.03189.9 (121.3–313.8)0.63
  • Data are presented as median (interquartile range), unless otherwise stated. Hb: haemoglobin; SOD: superoxide dismutase; GPx: glutathione peroxidase; M: male; F: female; ES: ever-smokers; NS: nonsmokers; AD: adenocarcinoma; TNM: tumour, node, metastasis.